Efficacy and safety of two doses of enoxaparin in women with thrombophilia and recurrent pregnancy loss: The LlVE-ENOX study

  • B. Brenner*
  • , R. Huffman
  • , H. Carp
  • , M. Dulitsky
  • , J. Younis
  • *Corresponding author for this work

Research output: Contribution to journalShort surveypeer-review

188 Scopus citations
Original languageEnglish
Pages (from-to)227-229
Number of pages3
JournalJournal of Thrombosis and Haemostasis
Volume3
Issue number2
DOIs
StatePublished - Feb 2005
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this